Full Text of SB1807 98th General Assembly
SB1807sam001 98TH GENERAL ASSEMBLY | Sen. William Delgado Filed: 3/7/2013
| | 09800SB1807sam001 | | LRB098 08608 KTG 42352 a |
|
| 1 | | AMENDMENT TO SENATE BILL 1807
| 2 | | AMENDMENT NO. ______. Amend Senate Bill 1807 as follows:
| 3 | | on page 1, line 4, after "by", by inserting "changing Section | 4 | | 5-5.12 and by"; and | 5 | | on page 1, by inserting immediately below line 5 the following:
| 6 | | "(305 ILCS 5/5-5.12) (from Ch. 23, par. 5-5.12)
| 7 | | Sec. 5-5.12. Pharmacy payments.
| 8 | | (a) Every request submitted by a pharmacy for reimbursement | 9 | | under this
Article for prescription drugs provided to a | 10 | | recipient of aid under this
Article shall include the name of | 11 | | the prescriber or an acceptable
identification number as | 12 | | established by the Department.
| 13 | | (b) Pharmacies providing prescription drugs under
this | 14 | | Article shall be reimbursed at a rate which shall include
a | 15 | | professional dispensing fee as determined by the Illinois
|
| | | 09800SB1807sam001 | - 2 - | LRB098 08608 KTG 42352 a |
|
| 1 | | Department, plus the current acquisition cost of the | 2 | | prescription
drug dispensed. The Illinois Department shall | 3 | | update its
information on the acquisition costs of all | 4 | | prescription drugs
no less frequently than every 30 days. | 5 | | However, the Illinois
Department may set the rate of | 6 | | reimbursement for the acquisition
cost, by rule, at a | 7 | | percentage of the current average wholesale
acquisition cost.
| 8 | | (c) (Blank).
| 9 | | (d) The Department shall review utilization of narcotic | 10 | | medications in the medical assistance program and impose | 11 | | utilization controls that protect against abuse.
| 12 | | (e) When making determinations as to which drugs shall be | 13 | | on a prior approval list, the Department shall include as part | 14 | | of the analysis for this determination, the degree to which a | 15 | | drug may affect individuals in different ways based on factors | 16 | | including the gender of the person taking the medication. | 17 | | (f) The Department shall cooperate with the Department of | 18 | | Public Health and the Department of Human Services Division of | 19 | | Mental Health in identifying psychotropic medications that, | 20 | | when given in a particular form, manner, duration, or frequency | 21 | | (including "as needed") in a dosage, or in conjunction with | 22 | | other psychotropic medications to a nursing home resident or to | 23 | | a resident of a facility licensed under the ID/DD Community | 24 | | Care Act, may constitute a chemical restraint or an | 25 | | "unnecessary drug" as defined by the Nursing Home Care Act or | 26 | | Titles XVIII and XIX of the Social Security Act and the |
| | | 09800SB1807sam001 | - 3 - | LRB098 08608 KTG 42352 a |
|
| 1 | | implementing rules and regulations. The Department shall | 2 | | require prior approval for any such medication prescribed for a | 3 | | nursing home resident or to a resident of a facility licensed | 4 | | under the ID/DD Community Care Act, that appears to be a | 5 | | chemical restraint or an unnecessary drug. The Department shall | 6 | | consult with the Department of Human Services Division of | 7 | | Mental Health in developing a protocol and criteria for | 8 | | deciding whether to grant such prior approval. | 9 | | (g) The Department may by rule provide for reimbursement of | 10 | | the dispensing of a 90-day supply of a generic or brand name, | 11 | | non-narcotic maintenance medication in circumstances where it | 12 | | is cost effective. | 13 | | (g-5) On and after July 1, 2012, the Department may require | 14 | | the dispensing of drugs to nursing home residents be in a 7-day | 15 | | supply or other amount less than a 31-day supply. The | 16 | | Department shall pay only one dispensing fee per 31-day supply. | 17 | | (h) Effective July 1, 2011, the Department shall | 18 | | discontinue coverage of select over-the-counter drugs, | 19 | | including analgesics and cough and cold and allergy | 20 | | medications. | 21 | | (h-5) On and after July 1, 2012, the Department shall | 22 | | impose utilization controls, including, but not limited to, | 23 | | prior approval on specialty drugs, oncolytic drugs, drugs for | 24 | | the treatment of HIV or AIDS, immunosuppressant drugs, and | 25 | | biological products in order to maximize savings on these | 26 | | drugs. The Department may adjust payment methodologies for |
| | | 09800SB1807sam001 | - 4 - | LRB098 08608 KTG 42352 a |
|
| 1 | | non-pharmacy billed drugs in order to incentivize the selection | 2 | | of lower-cost drugs. For drugs for the treatment of AIDS, the | 3 | | Department shall take into consideration the potential for | 4 | | non-adherence by certain populations, and shall develop | 5 | | protocols with organizations or providers primarily serving | 6 | | those with HIV/AIDS, as long as such measures intend to | 7 | | maintain cost neutrality with other utilization management | 8 | | controls such as prior approval.
For hemophilia, the Department | 9 | | shall develop a program of utilization review and control which | 10 | | may include, in the discretion of the Department, prior | 11 | | approvals. The Department may impose special standards on | 12 | | providers that dispense blood factors which shall include, in | 13 | | the discretion of the Department, staff training and education; | 14 | | patient outreach and education; case management; in-home | 15 | | patient assessments; assay management; maintenance of stock; | 16 | | emergency dispensing timeframes; data collection and | 17 | | reporting; dispensing of supplies related to blood factor | 18 | | infusions; cold chain management and packaging practices; care | 19 | | coordination; product recalls; and emergency clinical | 20 | | consultation. The Department may require patients to receive a | 21 | | comprehensive examination annually at an appropriate provider | 22 | | in order to be eligible to continue to receive blood factor. | 23 | | (i) On and after July 1, 2012, the Department shall reduce | 24 | | any rate of reimbursement for services or other payments or | 25 | | alter any methodologies authorized by this Code to reduce any | 26 | | rate of reimbursement for services or other payments in |
| | | 09800SB1807sam001 | - 5 - | LRB098 08608 KTG 42352 a |
|
| 1 | | accordance with Section 5-5e. | 2 | | (i) (Blank). | 3 | | (j) On and after July 1, 2012, the Department shall impose | 4 | | limitations on prescription drugs such that the Department | 5 | | shall not provide reimbursement for more than 4 prescriptions, | 6 | | including 3 brand name prescriptions, for distinct drugs in a | 7 | | 30-day period, unless prior approval is received for all | 8 | | prescriptions in excess of the 4-prescription limit. Drugs in | 9 | | the following therapeutic classes shall not be subject to prior | 10 | | approval as a result of the 4-prescription limit: | 11 | | immunosuppressant drugs, oncolytic drugs, and anti-retroviral | 12 | | drugs. Antipsychotic and anticonvulsant drugs used to treat | 13 | | severe mental illness shall not be subject to prior approval as | 14 | | a result of the 4-prescription limit and shall not count toward | 15 | | the monthly prescription limit when used for the following | 16 | | mental disorders: post-traumatic stress disorder, | 17 | | schizophrenia, schizoaffective disorder, bipolar disorder, or | 18 | | panic disorder. | 19 | | (k) No medication therapy management program implemented | 20 | | by the Department shall be contrary to the provisions of the | 21 | | Pharmacy Practice Act. | 22 | | (l) Any provider enrolled with the Department that bills | 23 | | the Department for outpatient drugs and is eligible to enroll | 24 | | in the federal Drug Pricing Program under Section 340B of the | 25 | | federal Public Health Services Act shall enroll in that | 26 | | program. No entity participating in the federal Drug Pricing |
| | | 09800SB1807sam001 | - 6 - | LRB098 08608 KTG 42352 a |
|
| 1 | | Program under Section 340B of the federal Public Health | 2 | | Services Act may exclude Medicaid from their participation in | 3 | | that program, although the Department may exclude entities | 4 | | defined in Section 1905(l)(2)(B) of the Social Security Act | 5 | | from this requirement. | 6 | | (Source: P.A. 96-1269, eff. 7-26-10; 96-1372, eff. 7-29-10; | 7 | | 96-1501, eff. 1-25-11; 97-38, eff. 6-28-11; 97-74, eff. | 8 | | 6-30-11; 97-333, eff. 8-12-11; 97-426, eff. 1-1-12; 97-689, | 9 | | eff. 6-14-12; 97-813, eff. 7-13-12; revised 8-3-12.)".
|
|